Disruption of central nervous system barriers in multiple sclerosis

Abbott, 2002, Astrocyte–endothelial interactions and blood–brain barrier permeability, J. Anat., 200, 629, 10.1046/j.1469-7580.2002.00064.x Abbott, 2006, Astrocyte–endothelial interactions at the blood–brain barrier, Nat. Rev. Neurosci., 7, 41, 10.1038/nrn1824 Adamson, 1999, Lymphocyte migration through brain endothelial cell monolayers involves signaling through endothelial ICAM-1 via a rho-dependent pathway, J. Immunol., 162, 2964, 10.4049/jimmunol.162.5.2964 Agrawal, 2006, Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis, J. Exp. Med., 203, 1007, 10.1084/jem.20051342 Agrawal, 2007, Immunopathogenesis of multiple sclerosis, Int. Rev. Neurobiol., 79, 99, 10.1016/S0074-7742(07)79005-0 Airas, 2006, Elevated serum soluble vascular adhesion protein-1 (VAP-1) in patients with active relapsing remitting multiple sclerosis, J. Neuroimmunol., 177, 132, 10.1016/j.jneuroim.2006.05.014 Alvarez, 2009, Astrocyte-secreted sonic hedgehog supports CNS anti-inflammatory activity and promotes optimal human blood brain barrier functioning, Clin. Immunol., 131, S34, 10.1016/j.clim.2009.03.096 Alvarez, 2007, Differential changes in junctional complex proteins suggest the ependymal lining as the main source of leukocyte infiltration into ventricles in murine neurocysticercosis, J. Neuroimmunol., 187, 102, 10.1016/j.jneuroim.2007.05.005 Alvarez, 2007, Evidence for differential changes of junctional complex proteins in murine neurocysticercosis dependent upon CNS vasculature, Brain Res., 1169, 98, 10.1016/j.brainres.2007.07.010 Andreeva, 2010, T-cadherin modulates endothelial barrier function, J. Cell. Physiol., 223, 94 Antonetti, 1999, Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors, J. Biol. Chem., 274, 23463, 10.1074/jbc.274.33.23463 Antonetti, 2002, Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation of occludin, J. Neurochem., 80, 667, 10.1046/j.0022-3042.2001.00740.x Armulik, 2005, Endothelial/pericyte interactions, Circ. Res., 97, 512, 10.1161/01.RES.0000182903.16652.d7 Asahi, 2001, Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood–brain barrier and white matter components after cerebral ischemia, J. Neurosci., 21, 7724, 10.1523/JNEUROSCI.21-19-07724.2001 Aurrand-Lions, 2001, Heterogeneity of endothelial junctions is reflected by differential expression and specific subcellular localization of the three JAM family members, Blood, 98, 3699, 10.1182/blood.V98.13.3699 Badovinac, 1998, Interleukin-1 receptor antagonist suppresses experimental autoimmune encephalomyelitis (EAE) in rats by influencing the activation and proliferation of encephalitogenic cells, J. Neuroimmunol., 85, 87, 10.1016/S0165-5728(98)00020-4 Balabanov, 1998, Role of the CNS microvascular pericyte in the blood–brain barrier, J. Neurosci. Res., 53, 637, 10.1002/(SICI)1097-4547(19980915)53:6<637::AID-JNR1>3.0.CO;2-6 Balabanov, 1996, CNS microvascular pericytes express macrophage-like function, cell surface integrin alpha M, and macrophage marker ED-2, Microvasc. Res., 52, 127, 10.1006/mvre.1996.0049 Ballabh, 2004, The blood–brain barrier: an overview: structure, regulation, and clinical implications, Neurobiol. Dis., 16, 1, 10.1016/j.nbd.2003.12.016 Bar-Or, 2003, Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis, Brain, 126, 2738, 10.1093/brain/awg285 Bartholomaus, 2009, Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions, Nature, 462, 94, 10.1038/nature08478 Barton, 2001, Junction adhesion molecule is a receptor for reovirus, Cell, 104, 441, 10.1016/S0092-8674(01)00231-8 Battistini, 2003, CD8+ T cells from patients with acute multiple sclerosis display selective increase of adhesiveness in brain venules: a critical role for P-selectin glycoprotein ligand-1, Blood, 101, 4775, 10.1182/blood-2002-10-3309 Bauer, 2009, Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement, J. Cereb. Blood Flow Metab. Bazzoni, 2004, Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis, Physiol. Rev., 84, 869, 10.1152/physrev.00035.2003 Bjartmar, 2003, Axonal degeneration and progressive neurologic disability in multiple sclerosis, Neurotox. Res., 5, 157, 10.1007/BF03033380 Blum, 1997, Cytoskeletal rearrangement mediates human microvascular endothelial tight junction modulation by cytokines, Am. J. Physiol., 273, H286 Bolton, 1998, Loss of the tight junction proteins occludin and zonula occludens-1 from cerebral vascular endothelium during neutrophil-induced blood–brain barrier breakdown in vivo, Neuroscience, 86, 1245, 10.1016/S0306-4522(98)00058-X Brennan, 1999, CD44 is involved in selective leucocyte extravasation during inflammatory central nervous system disease, Immunology, 98, 427, 10.1046/j.1365-2567.1999.00894.x Brown, 2004, Molecular mechanisms of cerebrospinal fluid production, Neuroscience, 129, 957, 10.1016/j.neuroscience.2004.07.003 Bruewer, 2003, Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms, J. Immunol., 171, 6164, 10.4049/jimmunol.171.11.6164 Bruewer, 2005, Interferon-gamma induces internalization of epithelial tight junction proteins via a macropinocytosis-like process, FASEB J., 19, 923, 10.1096/fj.04-3260com Bundgaard, 2008, All vertebrates started out with a glial blood–brain barrier 4-500 million years ago, Glia, 56, 699, 10.1002/glia.20642 Calabresi, 2001, T lymphocytes conditioned with Interferon beta induce membrane and soluble VCAM on human brain endothelial cells, J. Neuroimmunol., 115, 161, 10.1016/S0165-5728(01)00253-3 Calabria, 2008, A genomic comparison of in vivo and in vitro brain microvascular endothelial cells, J. Cereb. Blood Flow Metab., 28, 135, 10.1038/sj.jcbfm.9600518 Cannella, 1990, Upregulation and coexpression of adhesion molecules correlate with relapsing autoimmune demyelination in the central nervous system, J. Exp. Med., 172, 1521, 10.1084/jem.172.5.1521 Cannella, 1995, The adhesion molecule and cytokine profile of multiple sclerosis lesions, Ann. Neurol., 37, 424, 10.1002/ana.410370404 Cardona, 2008, Chemokines in and out of the central nervous system: much more than chemotaxis and inflammation, J. Leukoc. Biol., 10.1189/jlb.1107763 Carman, 2004, A transmigratory cup in leukocyte diapedesis both through individual vascular endothelial cells and between them, J. Cell Biol., 167, 377, 10.1083/jcb.200404129 Carrithers, 2002, Role of genetic background in P selectin-dependent immune surveillance of the central nervous system, J. Neuroimmunol., 129, 51, 10.1016/S0165-5728(02)00172-8 Cayrol, 2008, Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system, Nat. Immunol., 9, 137, 10.1038/ni1551 Charo, 2006, The many roles of chemokines and chemokine receptors in inflammation, N Engl J. Med., 354, 610, 10.1056/NEJMra052723 Chigaev, 2003, Alpha4beta1 integrin affinity changes govern cell adhesion, J. Biol. Chem., 278, 38174, 10.1074/jbc.M210472200 de Vries, 2002, Signal-regulatory protein alpha-CD47 interactions are required for the transmigration of monocytes across cerebral endothelium, J. Immunol., 168, 5832, 10.4049/jimmunol.168.11.5832 Dejana, 2000, The molecular organization of endothelial junctions and their functional role in vascular morphogenesis and permeability, Int. J. Dev. Biol., 44, 743 Dejana, 2008, The role of adherens junctions and VE-cadherin in the control of vascular permeability, J. Cell Sci., 121, 2115, 10.1242/jcs.017897 del Zoppo, 2006, Vascular matrix adhesion and the blood–brain barrier, Biochem. Soc. Trans., 34, 1261, 10.1042/BST0341261 Demeure, 2000, CD47 engagement inhibits cytokine production and maturation of human dendritic cells, J. Immunol., 164, 2193, 10.4049/jimmunol.164.4.2193 Dodelet-Devillers, 2009, Functions of lipid raft membrane microdomains at the blood–brain barrier, J. Mol. Med., 87, 765, 10.1007/s00109-009-0488-6 Dohgu, 2005, Brain pericytes contribute to the induction and up-regulation of blood–brain barrier functions through transforming growth factor-beta production, Brain Res., 1038, 208, 10.1016/j.brainres.2005.01.027 Dore-Duffy, 1995, Circulating, soluble adhesion proteins in cerebrospinal fluid and serum of patients with multiple sclerosis: correlation with clinical activity, Ann. Neurol., 37, 55, 10.1002/ana.410370111 Dore-Duffy, 1993, Expression of endothelial cell activation antigens in microvessels from patients with multiple sclerosis, Adv. Exp. Med. Biol., 331, 243, 10.1007/978-1-4615-2920-0_38 Doring, 2007, E- and P-selectin are not required for the development of experimental autoimmune encephalomyelitis in C57BL/6 and SJL mice, J. Immunol., 179, 8470, 10.4049/jimmunol.179.12.8470 Droogan, 1996, Serum and cerebrospinal fluid levels of soluble adhesion molecules in multiple sclerosis: predominant intrathecal release of vascular cell adhesion molecule-1, J. Neuroimmunol., 64, 185, 10.1016/0165-5728(95)00174-3 Dutta, 2007, Pathogenesis of axonal and neuronal damage in multiple sclerosis, Neurology, 68, S22, 10.1212/01.wnl.0000275229.13012.32 Engelhardt, 2006, Regulation of immune cell entry into the central nervous system, Results Probl. Cell Differ., 43, 259, 10.1007/400_020 Engelhardt, 2009, PSGL-1–the hidden player in T cell trafficking into the brain in multiple sclerosis?, J. Leukoc. Biol., 86, 1023, 10.1189/jlb.0509358 Engelhardt, 2008, Natalizumab: targeting alpha4-integrins in multiple sclerosis, Neurodegener. Dis., 5, 16, 10.1159/000109933 Engelhardt, 2005, P-selectin glycoprotein ligand 1 is not required for the development of experimental autoimmune encephalomyelitis in SJL and C57BL/6 mice, J. Immunol., 175, 1267, 10.4049/jimmunol.175.2.1267 Engelhardt, 2005, The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms, Trends Immunol., 26, 485, 10.1016/j.it.2005.07.004 Engelhardt, 2009, The blood–brain and the blood-cerebrospinal fluid barriers: function and dysfunction, Semin. Immunopathol., 31, 497, 10.1007/s00281-009-0177-0 Engelhardt, 2001, Involvement of the choroid plexus in central nervous system inflammation, Microsc. Res. Tech., 52, 112, 10.1002/1097-0029(20010101)52:1<112::AID-JEMT13>3.0.CO;2-5 Fischer, 2005, H2O2 induces paracellular permeability of porcine brain-derived microvascular endothelial cells by activation of the p44/42 MAP kinase pathway, Eur. J. Cell Biol., 84, 687, 10.1016/j.ejcb.2005.03.002 Friese, 2009, Pathogenic CD8(+) T cells in multiple sclerosis, Ann. Neurol., 66, 132, 10.1002/ana.21744 Frohman, 2005, Characterizing the mechanisms of progression in multiple sclerosis: evidence and new hypotheses for future directions, Arch. Neurol., 62, 1345, 10.1001/archneur.62.9.1345 Frohman, 2006, Multiple sclerosis—the plaque and its pathogenesis, N Engl J. Med., 354, 942, 10.1056/NEJMra052130 Frohman, 2005, Therapeutic considerations for disease progression in multiple sclerosis: evidence, experience, and future expectations, Arch. Neurol., 62, 1519, 10.1001/archneur.62.10.1519 Gavard, 2006, VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin, Nat. Cell Biol., 8, 1223, 10.1038/ncb1486 Gerhardt, 2000, N-cadherin mediates pericytic-endothelial interaction during brain angiogenesis in the chicken, Dev. Dyn., 218, 472, 10.1002/1097-0177(200007)218:3<472::AID-DVDY1008>3.0.CO;2-# Gijbels, 1990, Interleukin 6 production in the central nervous system during experimental autoimmune encephalomyelitis, Eur. J. Immunol., 20, 233, 10.1002/eji.1830200134 Gloor, 2001, Molecular and cellular permeability control at the blood–brain barrier, Brain Res. Brain Res. Rev., 36, 258, 10.1016/S0165-0173(01)00102-3 Gotsch, 1994, Expression of P-selectin on endothelial cells is upregulated by LPS and TNF-alpha in vivo, Cell Adhes. Commun., 2, 7, 10.3109/15419069409014198 Graber, 2005, Interferon-beta-1a induces increases in vascular cell adhesion molecule: implications for its mode of action in multiple sclerosis, J. Neuroimmunol., 161, 169, 10.1016/j.jneuroim.2004.11.017 Graesser, 2000, Distinct roles for matrix metalloproteinase-2 and alpha4 integrin in autoimmune T cell extravasation and residency in brain parenchyma during experimental autoimmune encephalomyelitis, J. Neuroimmunol., 109, 121, 10.1016/S0165-5728(00)00275-7 Greenwood, 2002, Lymphocyte migration into the central nervous system: implication of ICAM-1 signalling at the blood–brain barrier, Vascul. Pharmacol, 38, 315, 10.1016/S1537-1891(02)00199-4 Greenwood, 1995, Lymphocyte adhesion and transendothelial migration in the central nervous system: the role of LFA-1, ICAM-1, VLA-4 and VCAM-1. off, Immunology, 86, 408 Guillemot, 2006, Cingulin regulates claudin-2 expression and cell proliferation through the small GTPase RhoA, Mol. Biol. Cell, 17, 3569, 10.1091/mbc.E06-02-0122 Guillemot, 2008, The cytoplasmic plaque of tight junctions: a scaffolding and signalling center, Biochim. Biophys. Acta, 1778, 601, 10.1016/j.bbamem.2007.09.032 Harhaj, 2004, Regulation of tight junctions and loss of barrier function in pathophysiology, Int. J. Biochem. Cell Biol., 36, 1206, 10.1016/j.biocel.2003.08.007 Harris, 1991, Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: implications for clinical trials and natural history, Ann. Neurol., 29, 548, 10.1002/ana.410290515 Hartmann, 2007, The impact of glia-derived extracellular matrices on the barrier function of cerebral endothelial cells: an in vitro study, Exp. Cell Res., 313, 1318, 10.1016/j.yexcr.2007.01.024 Hawkins, 2005, The blood–brain barrier/neurovascular unit in health and disease, Pharmacol. Rev., 57, 173, 10.1124/pr.57.2.4 Hayashi, 2004, Effects of hypoxia on endothelial/pericytic co-culture model of the blood–brain barrier, Regul. Pept., 123, 77, 10.1016/j.regpep.2004.05.023 Hellstrom, 2001, Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis, J. Cell Biol., 153, 543, 10.1083/jcb.153.3.543 Henderson, 2009, Multiple sclerosis: distribution of inflammatory cells in newly forming lesions, Ann. Neurol., 66, 739, 10.1002/ana.21800 Hohlfeld, 2004, Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines, Proc. Natl Acad. Sci. USA, 101, 14599, 10.1073/pnas.0404874101 Hori, 2004, A pericyte-derived angiopoietin-1 multimeric complex induces occludin gene expression in brain capillary endothelial cells through Tie-2 activation in vitro, J. Neurochem., 89, 503, 10.1111/j.1471-4159.2004.02343.x Huppert, 2009, Cellular mechanisms of IL-17-induced blood–brain barrier disruption, FASEB J. Ifergan, 2008, The blood–brain barrier induces differentiation of migrating monocytes into Th17-polarizing dendritic cells, Brain, 131, 785, 10.1093/brain/awm295 Ifergan, 2006, Statins reduce human blood–brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis, Ann. Neurol., 60, 45, 10.1002/ana.20875 Igarashi, 1999, Glial cell line-derived neurotrophic factor induces barrier function of endothelial cells forming the blood–brain barrier, Biochem. Biophys. Res. Commun., 261, 108, 10.1006/bbrc.1999.0992 Ivanov, 2001, Expression of cell adhesion molecule T-cadherin in the human vasculature, Histochem. Cell Biol., 115, 231, 10.1007/s004180100252 Jaakkola, 2000, In vivo detection of vascular adhesion protein-1 in experimental inflammation, Am. J. Pathol., 157, 463, 10.1016/S0002-9440(10)64558-0 Jalkanen, 2007, The oxidase activity of vascular adhesion protein-1 (VAP-1) induces endothelial E- and P-selectins and leukocyte binding, Blood, 110, 1864, 10.1182/blood-2007-01-069674 Jalkanen, 2008, VAP-1 and CD73, endothelial cell surface enzymes in leukocyte extravasation, Arterioscler. Thromb. Vasc. Biol., 28, 18, 10.1161/ATVBAHA.107.153130 Jucker, 1996, Laminins in the adult and aged brain, Mol. Chem. Neuropathol., 28, 209, 10.1007/BF02815224 Kebir, 2009, Preferential recruitment of interferon-gamma-expressing T H 17 cells in multiple sclerosis, Ann. Neurol., 66, 390, 10.1002/ana.21748 Kebir, 2007, Human TH17 lymphocytes promote blood–brain barrier disruption and central nervous system inflammation, Nat. Med., 13, 1173, 10.1038/nm1651 Kerfoot, 2002, Overlapping roles of P-selectin and alpha 4 integrin to recruit leukocytes to the central nervous system in experimental autoimmune encephalomyelitis, J. Immunol., 169, 1000, 10.4049/jimmunol.169.2.1000 Kerfoot, 2006, Reevaluation of P-selectin and alpha 4 integrin as targets for the treatment of experimental autoimmune encephalomyelitis, J. Immunol., 176, 6225, 10.4049/jimmunol.176.10.6225 Kirk, 2003, Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood–brain barrier leakage and active demyelination, J. Pathol., 201, 319, 10.1002/path.1434 Kivisakk, 2003, Flow cytometric analysis of chemokine receptor expression on cerebrospinal fluid leukocytes, Methods, 29, 319, 10.1016/S1046-2023(02)00355-9 Kivisakk, 2003, Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin, Proc. Natl. Acad. Sci. U. S. A, 100, 8389, 10.1073/pnas.1433000100 Kniesel, 2000, Tight junctions of the blood–brain barrier, Cell. Mol. Neurobiol., 20, 57, 10.1023/A:1006995910836 Koning, 2007, Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions, Ann. Neurol., 62, 504, 10.1002/ana.21220 Kraus, 2004, Interferon-beta stabilizes barrier characteristics of brain endothelial cells in vitro, Ann. Neurol., 56, 192, 10.1002/ana.20161 Kraus, 2008, Interferon-beta stabilizes barrier characteristics of the blood–brain barrier in four different species in vitro, Mult. Scler., 14, 843, 10.1177/1352458508088940 Krueger, 2010, CNS pericytes: concepts, misconceptions, and a way out, Glia, 58, 1, 10.1002/glia.20898 Lai, 2005, Critical role of actin in modulating BBB permeability, Brain Res. Brain Res. Rev., 50, 7, 10.1016/j.brainresrev.2005.03.007 Lalor, 2007, Activation of vascular adhesion protein-1 on liver endothelium results in an NF-kappaB-dependent increase in lymphocyte adhesion, Hepatology, 45, 465, 10.1002/hep.21497 Lampugnani, 2007, The control of endothelial cell functions by adherens junctions, Novartis Found. Symp., 283, 4, 10.1002/9780470319413.ch2 Lassmann, 2005, Multiple sclerosis pathology: evolution of pathogenetic concepts, Brain Pathol., 15, 217, 10.1111/j.1750-3639.2005.tb00523.x Lassmann, 2001, Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy, Trends Mol. Med., 7, 115, 10.1016/S1471-4914(00)01909-2 Lee, 2007, Expression of the ATP-binding cassette membrane transporter, ABCG2, in human and rodent brain microvessel endothelial and glial cell culture systems, Pharm. Res., 24, 1262, 10.1007/s11095-007-9244-1 Lee, 2004, Hydrogen peroxide-induced alterations of tight junction proteins in bovine brain microvascular endothelial cells, Microvasc. Res., 68, 231, 10.1016/j.mvr.2004.07.005 Lee, 2003, SSeCKS regulates angiogenesis and tight junction formation in blood–brain barrier, Nat. Med., 9, 900, 10.1038/nm889 Leech, 2007, Persistent endothelial abnormalities and blood–brain barrier leak in primary and secondary progressive multiple sclerosis, Neuropathol. Appl. Neurobiol., 33, 86, 10.1111/j.1365-2990.2006.00781.x Ley, 2007, Getting to the site of inflammation: the leukocyte adhesion cascade updated, Nat. Rev. Immunol., 7, 678, 10.1038/nri2156 Lindahl, 1997, Pericyte loss and microaneurysm formation in PDGF-B-deficient mice, Science, 277, 242, 10.1126/science.277.5323.242 Lippoldt, 2000, Organization of choroid plexus epithelial and endothelial cell tight junctions and regulation of claudin-1, -2 and -5 expression by protein kinase C, NeuroReport, 11, 1427, 10.1097/00001756-200005150-00015 Luster, 2005, Immune cell migration in inflammation: present and future therapeutic targets, Nat. Immunol., 6, 1182, 10.1038/ni1275 Mahad, 2003, Longitudinal study of chemokine receptor expression on peripheral lymphocytes in multiple sclerosis: CXCR3 upregulation is associated with relapse, Mult. Scler., 9, 189, 10.1191/1352458503ms899oa Man, 2007, Inflammatory cell migration into the central nervous system: a few new twists on an old tale, Brain Pathol., 17, 243, 10.1111/j.1750-3639.2007.00067.x Martin-Padura, 1998, Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration, J. Cell Biol., 142, 117, 10.1083/jcb.142.1.117 Martinez-Estrada, 2001, Association of junctional adhesion molecule with calcium/calmodulin-dependent serine protein kinase (CASK/LIN-2) in human epithelial caco-2 cells, J. Biol. Chem., 276, 9291, 10.1074/jbc.M006991200 Matsuda, 1994, Expression of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 in the spinal cord of rats during acute experimental allergic encephalomyelitis, Autoimmunity, 19, 15, 10.3109/08916939409008004 Matter, 2003, Holey barrier: claudins and the regulation of brain endothelial permeability, J. Cell Biol., 161, 459, 10.1083/jcb.200304039 McDonnell, 1999, Serum soluble adhesion molecules in multiple sclerosis: raised sVCAM-1, sICAM-1 and sE-selectin in primary progressive disease, J. Neurol., 246, 87, 10.1007/s004150050313 McDonnell, 1998, Raised CSF levels of soluble adhesion molecules across the clinical spectrum of multiple sclerosis, J. Neuroimmunol., 85, 186, 10.1016/S0165-5728(98)00009-5 McFarland, 2007, Multiple sclerosis: a complicated picture of autoimmunity, Nat. Immunol., 8, 913, 10.1038/ni1507 McMahon, 2006, CNS dendritic cells: critical participants in CNS inflammation?, Neurochem. Int., 49, 195, 10.1016/j.neuint.2006.04.004 McQuaid, 2009, The effects of blood–brain barrier disruption on glial cell function in multiple sclerosis, Biochem. Soc. Trans., 37, 329, 10.1042/BST0370329 Mills, 2008, CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis, Proc. Natl Acad. Sci. USA, 105, 9325, 10.1073/pnas.0711175105 Nagasawa, 2006, Possible involvement of gap junctions in the barrier function of tight junctions of brain and lung endothelial cells, J. Cell. Physiol., 208, 123, 10.1002/jcp.20647 Naik, 2003, Signaling through JAM-1 and alphavbeta3 is required for the angiogenic action of bFGF: dissociation of the JAM-1 and alphavbeta3 complex, Blood, 102, 2108, 10.1182/blood-2003-04-1114 Nakagawa, 2007, Pericytes from brain microvessels strengthen the barrier integrity in primary cultures of rat brain endothelial cells, Cell. Mol. Neurobiol., 27, 687, 10.1007/s10571-007-9195-4 Nelson, 2008, Regulation of cell–cell adhesion by the cadherin-catenin complex, Biochem. Soc. Trans., 36, 149, 10.1042/BST0360149 Neuhaus, 1991, Induction of blood–brain barrier characteristics in bovine brain endothelial cells by rat astroglial cells in transfilter coculture, Ann. NY Acad. Sci., 633, 578, 10.1111/j.1749-6632.1991.tb15667.x Niemela, 2008, IFN-beta regulates CD73 and adenosine expression at the blood–brain barrier, Eur. J. Immunol., 38, 2718, 10.1002/eji.200838437 Nitta, 2003, Size-selective loosening of the blood–brain barrier in claudin-5-deficient mice, J. Cell Biol., 161, 653, 10.1083/jcb.200302070 Nottebaum, 2008, VE-PTP maintains the endothelial barrier via plakoglobin and becomes dissociated from VE-cadherin by leukocytes and by VEGF, J. Exp. Med., 205, 2929, 10.1084/jem.20080406 Nourshargh, 2006, The role of JAM-A and PECAM-1 in modulating leukocyte infiltration in inflamed and ischemic tissues, J. Leukoc. Biol., 80, 714, 10.1189/jlb.1105645 Nusrat, 2000, Molecular physiology and pathophysiology of tight junctions. IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells, Am. J. Physiol. Gastrointest. Liver Physiol., 279, G851, 10.1152/ajpgi.2000.279.5.G851 O'Rourke, 2007, Benefit of inhibiting SSAO in relapsing experimental autoimmune encephalomyelitis, J. Neural Transm., 114, 845, 10.1007/s00702-007-0699-3 Oldenborg, 2000, Role of CD47 as a marker of self on red blood cells, Science, 288, 2051, 10.1126/science.288.5473.2051 Ozaki, 1999, Cutting edge: combined treatment of TNF-alpha and IFN-gamma causes redistribution of junctional adhesion molecule in human endothelial cells, J. Immunol., 163, 553, 10.4049/jimmunol.163.2.553 Padden, 2007, Differences in expression of junctional adhesion molecule-A and beta-catenin in multiple sclerosis brain tissue: increasing evidence for the role of tight junction pathology, Acta Neuropathol., 113, 177, 10.1007/s00401-006-0145-x Paik, 2004, Sphingosine 1-phosphate receptor regulation of N-cadherin mediates vascular stabilization, Genes Dev., 18, 2392, 10.1101/gad.1227804 Paris, 2008, Structural organization of the tight junctions, Biochim. Biophys. Acta, 1778, 646, 10.1016/j.bbamem.2007.08.004 Park, 2008, Meteorin regulates angiogenesis at the gliovascular interface, Glia, 56, 247, 10.1002/glia.20600 Persidsky, 2006, Blood–brain barrier: structural components and function under physiologic and pathologic conditions, J. Neuroimmune Pharmacol., 1, 223, 10.1007/s11481-006-9025-3 Phelps, 1972, The development of glio-vascular relationships in the rat spinal cord. An electron microscopic study, Z. Zellforsch. Mikrosk. Anat., 128, 555, 10.1007/BF00306988 Piccio, 2002, Molecular mechanisms involved in lymphocyte recruitment in inflamed brain microvessels: critical roles for P-selectin glycoprotein ligand-1 and heterotrimeric G(i)-linked receptors, J. Immunol., 168, 1940, 10.4049/jimmunol.168.4.1940 Plumb, 2002, Abnormal endothelial tight junctions in active lesions and normal-appearing white matter in multiple sclerosis, Brain Pathol., 12, 154, 10.1111/j.1750-3639.2002.tb00430.x Pokutta, 2008, Biochemical and structural analysis of alpha-catenin in cell–cell contacts, Biochem. Soc. Trans., 36, 141, 10.1042/BST0360141 Prat, 2005, Pathogenesis of multiple sclerosis, Curr. Opin. Neurol., 18, 225, 10.1097/01.wco.0000169737.99040.31 Prat, 2000, B7 expression and antigen presentation by human brain endothelial cells: requirement for proinflammatory cytokines, J. Neuropathol. Exp. Neurol., 59, 129, 10.1093/jnen/59.2.129 Prat, 2001, Glial cell influence on the human blood–brain barrier, Glia, 36, 145, 10.1002/glia.1104 Rajasekaran, 1996, Catenins and zonula occludens-1 form a complex during early stages in the assembly of tight junctions, J. Cell Biol., 132, 451, 10.1083/jcb.132.3.451 Ransohoff, 2002, The chemokine system in neuroinflammation: an update, J. Infect. Dis., 186, S152, 10.1086/344266 Ransohoff, 2007, “Thinking without thinking” about natalizumab and PML, J. Neurol. Sci., 259, 50, 10.1016/j.jns.2006.04.011 Ransohoff, 2003, Three or more routes for leukocyte migration into the central nervous system, Nat. Rev. Immunol., 3, 569, 10.1038/nri1130 Rebenko-Moll, 2006, Chemokines, mononuclear cells and the nervous system: heaven (or hell) is in the details, Curr. Opin. Immunol., 18, 683, 10.1016/j.coi.2006.09.005 Reboldi, 2009, C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE, Nat. Immunol., 10, 514, 10.1038/ni.1716 Reuss, 2003, Functions of fibroblast growth factor (FGF)-2 and FGF-5 in astroglial differentiation and blood–brain barrier permeability: evidence from mouse mutants, J. Neurosci., 23, 6404, 10.1523/JNEUROSCI.23-16-06404.2003 Rubina, 2007, T-cadherin suppresses angiogenesis in vivo by inhibiting migration of endothelial cells, Angiogenesis, 10, 183, 10.1007/s10456-007-9072-2 Saitou, 2000, Complex phenotype of mice lacking occludin, a component of tight junction strands, Mol. Biol. Cell, 11, 4131, 10.1091/mbc.11.12.4131 Salmi, 1992, A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans, Science, 257, 1407, 10.1126/science.1529341 Schreibelt, 2007, Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling, FASEB J., 21, 3666, 10.1096/fj.07-8329com Schreibelt, 2006, Lipoic acid affects cellular migration into the central nervous system and stabilizes blood–brain barrier integrity, J. Immunol., 177, 2630, 10.4049/jimmunol.177.4.2630 Schreibelt, 2007, Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology, Brain Res. Rev., 56, 322, 10.1016/j.brainresrev.2007.07.005 Schreibelt, 2008, Protective effects of peroxiredoxin-1 at the injured blood–brain barrier, Free Radic. Biol. Med., 45, 256, 10.1016/j.freeradbiomed.2008.03.024 Schulz, 2005, The circumventricular organs participate in the immunopathogenesis of experimental autoimmune encephalomyelitis, Cerebrospinal. Fluid Res, 2, 8, 10.1186/1743-8454-2-8 Schulze, 1993, Immunohistochemical localization of adherens junction components in blood–brain barrier microvessels of the rat, J. Cell Sci., 104, 773, 10.1242/jcs.104.3.773 Segal, 1993, Extracellular and cerebrospinal fluids, J. Inherit. Metab. Dis., 16, 617, 10.1007/BF00711896 Shamri, 2005, Lymphocyte arrest requires instantaneous induction of an extended LFA-1 conformation mediated by endothelium-bound chemokines, Nat. Immunol., 6, 497, 10.1038/ni1194 Sharief, 1993, Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-alpha and blood–brain barrier damage, J. Neuroimmunol., 43, 15, 10.1016/0165-5728(93)90070-F Shaw, 1995, Measurement of immune markers in the serum and cerebrospinal fluid of multiple sclerosis patients during clinical remission, J. Neurol., 242, 53, 10.1007/BF00887815 Shin, 1995, The subarachnoid space as a site for precursor T cell proliferation and effector T cell selection in experimental autoimmune encephalomyelitis, J. Neuroimmunol., 56, 171, 10.1016/0165-5728(94)00144-D Sixt, 2001, Endothelial cell laminin isoforms, laminins 8 and 10, play decisive roles in T cell recruitment across the blood–brain barrier in experimental autoimmune encephalomyelitis, J. Cell Biol., 153, 933, 10.1083/jcb.153.5.933 Sobel, 1990, Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system, Am. J. Pathol., 136, 1309 Soilu-Hanninen, 2005, Hyaluronate receptor (CD44) and integrin alpha4 (CD49d) are up-regulated on T cells during MS relapses, J. Neuroimmunol., 166, 189, 10.1016/j.jneuroim.2005.05.008 Sonobe, 2009, Interleukin-25 expressed by brain capillary endothelial cells maintains blood–brain barrier function in a protein kinase Cepsilon-dependent manner, J. Biol. Chem., 284, 31834, 10.1074/jbc.M109.025940 Sozen, 2009, Role of interleukin-1beta in early brain injury after subarachnoid hemorrhage in mice, Stroke, 40, 2519, 10.1161/STROKEAHA.109.549592 Stamatovic, 2006, Inflammation and brain edema: new insights into the role of chemokines and their receptors, Acta Neurochir. Suppl., 96, 444, 10.1007/3-211-30714-1_91 Stamatovic, 2009, Caveolae-mediated internalization of occludin and claudin-5 during CCL2-induced tight junction remodeling in brain endothelial cells, J. Biol. Chem., 284, 19053, 10.1074/jbc.M109.000521 Stamatovic, 2005, Monocyte chemoattractant protein-1 regulation of blood–brain barrier permeability, J. Cereb. Blood Flow Metab., 25, 593, 10.1038/sj.jcbfm.9600055 Stefanidakis, 2008, Endothelial CD47 interaction with SIRPgamma is required for human T-cell transendothelial migration under shear flow conditions in vitro, Blood, 112, 1280, 10.1182/blood-2008-01-134429 Steffen, 1996, ICAM-1, VCAM-1, and MAdCAM-1 are expressed on choroid plexus epithelium but not endothelium and mediate binding of lymphocytes in vitro, Am. J. Pathol., 148, 1819 Steinman, 2005, Blocking adhesion molecules as therapy for multiple sclerosis: natalizumab, Nat. Rev. Drug Discov., 4, 510, 10.1038/nrd1752 Tao-Cheng, 1988, Development of membrane interactions between brain endothelial cells and astrocytes in vitro, Int. J. Dev. Neurosci., 6, 25, 10.1016/0736-5748(88)90026-3 Trapp, 2008, Multiple sclerosis: an immune or neurodegenerative disorder?, Annu. Rev. Neurosci., 31, 247, 10.1146/annurev.neuro.30.051606.094313 Vajkoczy, 2001, Alpha4-integrin-VCAM-1 binding mediates G protein-independent capture of encephalitogenic T cell blasts to CNS white matter microvessels, J. Clin. Invest., 108, 557, 10.1172/JCI12440 van Horssen, 2006, Extensive extracellular matrix depositions in active multiple sclerosis lesions, Neurobiol. Dis., 24, 484, 10.1016/j.nbd.2006.08.005 van Horssen, 2007, The extracellular matrix in multiple sclerosis pathology, J. Neurochem., 103, 1293, 10.1111/j.1471-4159.2007.04897.x Van Itallie, 2004, The role of claudins in determining paracellular charge selectivity, Proc. Am. Thorac. Soc., 1, 38, 10.1513/pats.2306013 van der Valk, 2009, Preactive lesions in multiple sclerosis, Curr. Opin. Neurol., 22, 207, 10.1097/WCO.0b013e32832b4c76 Verbeek, 1995, T lymphocyte adhesion to human brain pericytes is mediated via very late antigen-4/vascular cell adhesion molecule-1 interactions, J. Immunol., 154, 5876, 10.4049/jimmunol.154.11.5876 Vercellino, 2008, Involvement of the choroid plexus in multiple sclerosis autoimmune inflammation: a neuropathological study, J. Neuroimmunol., 199, 133, 10.1016/j.jneuroim.2008.04.035 Vorbrodt, 2003, Molecular anatomy of intercellular junctions in brain endothelial and epithelial barriers: electron microscopist's view, Brain Res. Brain Res. Rev., 42, 221, 10.1016/S0165-0173(03)00177-2 Wachtel, 1999, Occludin proteolysis and increased permeability in endothelial cells through tyrosine phosphatase inhibition, J. Cell Sci., 112, 4347, 10.1242/jcs.112.23.4347 Washington, 1994, Expression of immunologically relevant endothelial cell activation antigens on isolated central nervous system microvessels from patients with multiple sclerosis, Ann. Neurol., 35, 89, 10.1002/ana.410350114 Waubant, 2006, Biomarkers indicative of blood–brain barrier disruption in multiple sclerosis, Dis. Markers, 22, 235, 10.1155/2006/709869 Weis, 2006, Re-solving the cadherin–catenin–actin conundrum, J. Biol. Chem., 281, 35593, 10.1074/jbc.R600027200 Wojciak-Stothard, 1998, Regulation of TNF-alpha-induced reorganization of the actin cytoskeleton and cell–cell junctions by Rho, Rac, and Cdc42 in human endothelial cells, J. Cell. Physiol., 176, 150, 10.1002/(SICI)1097-4652(199807)176:1<150::AID-JCP17>3.0.CO;2-B Wojciak-Stothard, 2001, Rho and Rac but not Cdc42 regulate endothelial cell permeability, J. Cell Sci., 114, 1343, 10.1242/jcs.114.7.1343 Wolburg, 2002, Tight junctions of the blood–brain barrier: development, composition and regulation, Vascul. Pharmacol., 38, 323, 10.1016/S1537-1891(02)00200-8 Wolburg, 2010, Choroid plexus: biology and pathology, Acta Neuropathol., 119, 75, 10.1007/s00401-009-0627-8 Wong, 1992, Upregulation of intercellular adhesion molecule-1 (ICAM-1) expression in primary cultures of human brain microvessel endothelial cells by cytokines and lipopolysaccharide, J. Neuroimmunol., 39, 11, 10.1016/0165-5728(92)90170-P Wong, 1999, In vitro adhesion and migration of T lymphocytes across monolayers of human brain microvessel endothelial cells: regulation by ICAM-1, VCAM-1, E-selectin and PECAM-1, J. Neuropathol. Exp. Neurol., 58, 138, 10.1097/00005072-199902000-00004 Wong, 1999, Cadherin-5 redistribution at sites of TNF-alpha and IFN-gamma-induced permeability in mesenteric venules, Am. J. Physiol., 276, H736 Wosik, 2007, Angiotensin II controls occludin function and is required for blood brain barrier maintenance: relevance to multiple sclerosis, J. Neurosci., 27, 9032, 10.1523/JNEUROSCI.2088-07.2007 Wu, 2009, Endothelial basement membrane laminin alpha5 selectively inhibits T lymphocyte extravasation into the brain, Nat. Med., 15, 519, 10.1038/nm.1957 Yamao, 2002, Negative regulation of platelet clearance and of the macrophage phagocytic response by the transmembrane glycoprotein SHPS-1, J. Biol. Chem., 277, 39833, 10.1074/jbc.M203287200 Yang, 2007, Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat, J. Cereb. Blood Flow Metab., 27, 697, 10.1038/sj.jcbfm.9600375 Yong, 1998, Interferon beta in the treatment of multiple sclerosis: mechanisms of action, Neurology, 51, 682, 10.1212/WNL.51.3.682 Youakim, 1999, Interferon-gamma decreases barrier function in T84 cells by reducing ZO-1 levels and disrupting apical actin, Am. J. Physiol., 276, G1279 Zhadanov, 1999, Absence of the tight junctional protein AF-6 disrupts epithelial cell–cell junctions and cell polarity during mouse development, Curr. Biol., 9, 880, 10.1016/S0960-9822(99)80392-3 Zlokovic, 2008, The blood–brain barrier in health and chronic neurodegenerative disorders, Neuron, 57, 178, 10.1016/j.neuron.2008.01.003